What Is Fragile X Syndrome?
Fragile X syndrome is the most common cause of inherited intellectual disability.¹ Fragile X syndrome testing can reveal a range of outcomes, some of which may carry health implications for you, not just for a future child. jscreen currently offers fragile X syndrome testing as part of the reproductive carrier screening panel.
Fragile X syndrome is an X-linked condition that causes a range of developmental, intellectual, and behavioral differences that tend to be more pronounced in males.¹ As infants, children with fragile X syndrome may have weak muscle tone, digestive reflux, frequent ear infections, and their motor, speech, and developmental milestones are often delayed. As they grow, children may show autism-like behaviors, anxiety, hyperactivity, sensory sensitivities, and difficulty with social cues.¹
Fragile X syndrome affects roughly 1 in 7,000 males and 1 in 11,000 females.² Males are affected more often and more severely because they only have one X chromosome, so there's no second, unaffected copy to provide “backup” so to speak. Females have two X chromosomes, so the unaffected copy of the gene can reduce the severity of symptoms, and some women with even a full gene mutation (see below) show few or no signs of the condition at all.¹
The FMR1 Gene and Why This Condition Is Unique
Fragile X syndrome is associated with a gene change in the FMR1 gene, located on the X chromosome. This gene contains a segment of DNA that repeats itself, called a CGG repeat. The number of times that segment repeats itself helps determine a person's personal risk and risk of passing on the condition.³ DNA testing for Fragile X syndrome essentially counts the amount of repeats and uses this information to predict certain risks. For fragile X testing results, there are four categories, based on CGG repeat count:
Normal
No increased chance of having a child with fragile X syndrome
Intermediate (gray zone)
Not associated with fragile X syndrome or its related conditions. A repeat number in this range can change size across generations
Premutation
No fragile X syndrome symptoms expected, but repeats in this range carry their own health considerations for the carrier and may expand in future generations
Full Mutation
Associated with fragile X syndrome
The specifics of risk and inheritance with fragile X syndrome work differently from most conditions on a carrier screening panel. Typically, an individual tested is either found to be decisively a carrier or not. Additionally, carrier status typically has no effect on one’s own health. This is one way that fragile X syndrome differs from other conditions; a premutation result means you are not affected by the syndrome itself, but may face certain health complications of your own later in life.³ Furthermore, expansions in this gene that contribute to disease risk may not stay stable as they pass from generation to generation (in this case, via the maternal line) as opposed to other mutations that are not expected to change further.
Why Fragile X Syndrome Genetic Testing Matters
Fragile X syndrome doesn't have a cure, but early identification of the condition allows access to developmental support, therapies, and educational resources as soon as possible.¹ Testing before or during pregnancy gives you time to understand your reproductive options and plan ahead, rather than learning about a CGG repeat change only after a child shows developmental delays. Technology such as IVF with PGT (preimplantation genetic testing)
Knowledge of carrier status also allows you and your doctor to monitor for early signs and take a proactive approach to your personal care, if relevant.
Premutation Carrier Health Considerations
Men and women with premutations are not considered affected by fragile X syndrome, and most are intellectually and developmentally unaffected.¹ However, a premutation is linked to two conditions that can appear later in life.
Who Should Consider Fragile X Syndrome Testing?
Testing for fragile X syndrome is worth considering for individuals of all backgrounds and ethnicities, well before you're expecting rather than after. Testing is especially appropriate if:
You Have a Family History of Fragile X Syndrome or Related Conditions
If fragile X syndrome, FXTAS, or unexplained early ovarian insufficiency runs in your family, testing can clarify your own status and your risk of passing it on.
You're Planning Ahead of Pregnancy
Understanding your CGG repeat status before conceiving gives you the greatest range of reproductive options.
You Have Unexplained Fertility Concerns or Early Menopause
Since premutation carriers are at higher risk for FXPOI, testing can help explain unexplained fertility struggles or menstrual changes before age 40.⁴
You're Already Pregnant
Testing can still provide valuable information during pregnancy, and a genetic counselor can help you understand what your results mean for your current pregnancy.
Easy Steps from Home to Results
Order Your Kit
Register online and receive a saliva collection kit shipped directly to your home within a few days.
Collect Your Sample
Provide a saliva sample at home, following the instructions included in your kit.
Lab Analysis
Your sample is analyzed at a CLIA-accredited laboratory using DNA testing for Fragile X syndrome, which quantifies the number of CGG repeats in your FMR1 genes. Note, this testing is only run for females, who have the potential to pass FMR1 mutations on to the next generation.
Receive Results
Receive your results within 3 to 4 weeks of your sample arriving at the lab. Especially if results indicate a CGG expansion, we strongly recommend a complimentary consultation with a certified genetic counselor to review your findings, since these results can carry health implications beyond family planning.
Affordable Access for Everyone
Insurance Billing
Self-Pay Option
Understanding Your Fragile X Syndrome Testing Results
Normal
Intermediate (Gray Zone)
Premutation
Full Mutation
Get Fragile X Syndrome Genetic Testing
Frequently Asked Questions
Can you test for fragile X syndrome?
Yes. Fragile X syndrome testing measures the number of CGG repeats in your FMR1 gene to determine which of the four categories you fall into: normal, intermediate, premutation, or full mutation.³
What is a premutation, and is it the same as being a carrier?
Not exactly. A premutation means you have between 55 and 200 CGG repeats in FMR1.³ You are not affected by fragile X syndrome, but unlike a typical carrier result for other conditions, a premutation carries its own health considerations, including a higher risk for FXTAS and FXPOI.⁴
What health risks are linked to a fragile X premutation?
The two main risks are fragile X-associated tremor/ataxia syndrome (FXTAS), which affects coordination, balance, and memory later in life, and fragile X-associated primary ovarian insufficiency (FXPOI), which can affect fertility and cause early menopause.¹ About 40% of male premutation carriers over 50 develop FXTAS, and about 20% of female premutation carriers develop FXPOI.⁴
How does DNA testing for Fragile X syndrome work from home?
With a reproductive carrier screening via jscreen, the whole process happens from home. You order a kit online, provide a saliva sample using the instructions included, and mail it back using the prepaid materials in the kit. Your sample is analyzed at a CLIA-accredited laboratory, and results are typically available between 3 and 4 weeks after your sample arrives at the lab.
Do I need genetic counseling after my results?
It isn't required, but it's strongly recommended for any result other than a normal result, since intermediary, premutation and full mutation results carry implications that go beyond a straightforward carrier or non-carrier result. Every screening via jscreen includes access to a complimentary consultation with a board certified genetic counselor. We strongly recommend testing prior to conception, which allows for the greatest range of reproductive options.
Still Have Questions?
We’d love to hear from you! Check our FAQ page, or contact us.
References
- Fragile X Syndrome (FXS): What It Is, Symptoms & Treatment. Cleveland Clinic. Last updated February 7, 2024. Accessed August 19, 2026.
https://my.clevelandclinic.org/health/diseases/5476-fragile-x-syndrome - Prevalence: How Common Is Fragile X? National Fragile X Foundation (NFXF). Last updated April 23, 2026. Accessed August 19, 2026.
https://fragilex.org/fx/prevalence/